Pharmafile Logo
Pharmafocus logo
Advanced Search

Digital Pharma: UK healthcare Twitter group is launched

March 16, 2011
Medical Communications Digital Pharma blog, Twitter, hcsmeu, hcsmuk

A new Twitter group is launched today to provide a forum for discussing social media and its impact on healthcare …

News

New Regulatory & Pharmacovigilance training webinars available

March 15, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Wainwright Associates have designed a multitude of courses on general and specific regulatory & pharmacovigilance topics including:• Analytical Validation• Appeals, Hearings and …

News
Press release
Pfizer's Sandwich research facility

Pfizer’s CRO plans for Sandwich will have limited impact

March 15, 2011
Business Services, Research and Development Jobs, Kent, Pfizer, Sandwich, job cuts

Pfizer’s efforts to attract contract research organisations to take over part of its Sandwich research site will only benefit a …

News

CO2 could simplify pharma processing, say US chemists

March 15, 2011
C02, carbon dioxide, manufacturing techniques, pharma manufacturing

Carbon dioxide could hold the key to a quicker, easier and greener method for manufacturing a range of commonly-used pharmaceuticals, …

News

J&J charged with US manufacturing violations

March 15, 2011
Manufacturing and Production J&J, JJ, Johnson and Johnson, McNeil Consumer Healthcare, McNeil Fort Washington, McNeil recall, Motrin recall, manufacturing compliance, pharma manufacturing, recalls

Johnson & Johnson subsidiary McNeil Consumer Healthcare has been officially charged with manufacturing and distributing drugs in violation of federal …

News

Daiichi recalls contaminated paediatric vaccines

March 15, 2011
Manufacturing and Production ActHIB, Daiichi Sankyo, manufacturing compliance, padiatric vaccine recall, recalls, vaccines

Japanese drugmaker Daiichi Sankyo has recalled around 1.3 million doses of the paediatric vaccine ActHIB, manufactured by Sanofi-Aventis, because of …

News

Lib Dems push for major amendments in Health Bill

March 14, 2011
Dr Even Harris, Health and Social Care Bill, Liberal Democrat health policy, NHS, NHS reforms

Liberal Democrats activists have rejected the government’s NHS reform programme, voting overwhelmingly in favour of a major amendment to the …

News

Bayer-helmed oncology biomarker project launched

March 14, 2011
Manufacturing and Production, Research and Development AstraZeneca, Bayer, Janssen, Max Planck Institute, Merck, OncoTrack, Pfizer, Roche, biomarkers, oncology

A project to develop the next generation of oncology biomarkers has been launched in Berlin. The pharma industry and European …

News

Pfizer sells Irish manufacturing facility to Amgen

March 14, 2011
Manufacturing and Production Amgen, Dun Laoghaire, Ireland, Pfizer, pharma manufacturing, pharma manufacturing in Ireland

Amgen has come to the rescue of 280 workers whose jobs were threatened by the closure of a manufacturing facility …

News

Diabetes trial disappointment for GSK and Tolerx

March 14, 2011
Research and Development DEFEND-1, DEFEND-2, GSK, GlaxoSmithKline, Tolerx, diabetes, otelixizumab, type I diabetes

GSK and Tolerx’s type I diabetes drug otelixizumab has failed to meet its primary endpoint in a late-stage trial. Anti-CD3 …

News
New Zealand haka

Anticipating the competition in pharma

March 14, 2011
Sales and Marketing business intelligence, competitor intelligence, market research

Sun Tzu, the ancient Chinese military strategist wrote: “Conquerors estimate before the war begins, and they consider everything; the defeated …

Feature
Yondelis - tunicate Ecteinascidia turbin

NICE rejects PharmaMar’s ovarian cancer drug Yondelis

March 14, 2011
Sales and Marketing Cancer, NICE, PharmaMar, Trabectedin, Yondelis, ovarian cancer

NICE has rejected PharmaMar’s ovarian cancer drug in final draft guidance due to a lack of ‘robust’ data. Yondelis (trabectedin) …

News

Former Gates Foundation director joins Sanofi

March 14, 2011
Research and Development Dr Richard Klausner, Sanofi-Aventis, appointment, research and development

Sanofi-Aventis has appointed a former Gates Foundation director to chair its strategic development and scientific advisory council. Dr Richard Klausner …

News

Perry Evans to lead RSA Interims

March 11, 2011
Business Services, Sales and Marketing Perry Evens, RSA Interims, appointment, business services, rsa, sales and marketing

UK-based life science search company RSA has appointed Perry Evans director of RSA Interims. He joined the company in 2006 …

Appointment

Sanofi lung cancer drug fails in late-stage trial

March 11, 2011
Research and Development Cancer, NSCLC, Regeneron, Sanofi-Aventis, aflibercept, non-small cell lung cancer

Sanofi-Aventis’ lung cancer drug aflibercept has failed to meet its primary endpoint in a phase III trial. The late-stage VITAL …

News

UK dementia awareness campaign launched

March 11, 2011
Medical Communications dementia, disease awareness, disease awareness campaigns, stroke

The Department of Health has launched a £1.2 million awareness campaign which aims to alert people to the early signs …

News

Tangles and plaques: unlocking the secrets of Alzheimer’s disease

March 11, 2011
Research and Development, Sales and Marketing Alzheimer's, Alzheimer's disease, bapineuzumab, dimebon, latrepirdine, solanezumab

Despite many years of relentless research efforts, Alzheimer’s disease, the most common form of dementia, remains impossible to cure. According …

Feature

NICE stands firm on Tarceva

March 11, 2011
Cancer, NICE, Roche, Tarceva, erlotinib

NICE has not recommended Roche’s lung cancer drug Tarceva because its effectiveness as a maintenance therapy remains unclear. NICE is …

News
systemic lupus erythematosus (SLE)

US approval for GSK’s lupus treatment Benlysta

March 10, 2011
Sales and Marketing Benlysta, GSK, GlaxoSmithKline, Human Genome Sciences, Lupus, belimumab, systemic lupus erythematosus

GlaxoSmithKline’s lupus treatment Benylsta has won an historic approval in the US, but will have to prove its safety record …

News

Matthew Kent moves to 90TEN Healthcare

March 10, 2011
Medical Communications 90Ten Healthcare, Matthew Kent, appointment, medical communications

90TEN Healthcare has appointed Matthew Kent as an associate director and to its senior management team. He joins the company …

Appointment
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026